Esperion Therapeutics (ESPR) Cash from Investing Activities Growth (1y) (2013 - 2024)
Esperion Therapeutics (ESPR) Cash from Investing Activities Growth (1y) (2013 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 13.93% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 57.14% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 551.55% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | -3,664.79% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -3.45% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -22,919.16% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 140.78% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 52.90% |
| 10 | Esperion Therapeutics | 49.69 Mn | -118.16 Mn | 45.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -100.44% |
| Mar 31, 2024 | -100.29% |
| Jun 30, 2023 | 250.00% |
| Mar 31, 2023 | 238.11% |
| Dec 31, 2022 | 76.64% |
| Dec 31, 2021 | -298.26% |
| Dec 31, 2020 | -341.98% |
| Sep 30, 2020 | 143.91% |
| Jun 30, 2020 | -80.87% |
| Mar 31, 2020 | -41.81% |
| Dec 31, 2019 | -107.44% |
| Sep 30, 2019 | -113.27% |
| Jun 30, 2019 | -15.38% |
| Mar 31, 2019 | 50.90% |
| Dec 31, 2018 | -20.31% |
| Sep 30, 2018 | 131.39% |
| Jun 30, 2018 | 16.48% |
| Mar 31, 2018 | 87.30% |
| Dec 31, 2017 | 524.34% |
| Sep 30, 2017 | -1,075.69% |